Addressing parental concerns about the COVID-19 vaccine

Podcast

Contemporary Pediatrics sat down with Dr. Donna Hallas to discuss how to communicate with parents as well as how to address vaccines missed because of the pandemic.

The COVID-19 vaccine offers some challenges for addressing the vaccine hesitant parent. We sat down with Dr. Donna Hallas to discuss how to communicate with parents as well as how to address vaccines missed because of the pandemic.

Recent Videos
Robert Frenck, MD | Image credit: Cincinnati Children's
COVID-19 Roundtable: Considering off label therapies
COVID-19 Therapy Roundtable: Focusing on Inpatient Care | Image credit: Production Perig
Image credit: Production Perig
Tina Tan, MD
Octavio Ramilo
Octavio Ramilo, MD
Tina Tan, MD, FAAP, FIDSA, FPIDS
Related Content
Robert Frenck, MD

Discussing pediatric vaccination with vaccine-hesitant parents

Joshua Fitch, Senior Editor
January 20th 2025
Article

Robert Frenck, MD, offers several practical tips to use when discussing pediatric vaccination among vaccine-hesitant parents.

What's going on with polio, monkeypox, and COVID-19

What's going on with polio, monkeypox, and COVID-19

Miranda Hester
August 19th 2022
Podcast

The news is full of stories about monkeypox, the recent changes to COVID-19 guidance, and the return of polio cases. What do clinicians need to know?

Weekly review: New peanut patch data, norovirus outbreaks, and more

Weekly review: New peanut patch data, norovirus outbreaks, and more

Joshua Fitch, Senior Editor
January 13th 2025
Article

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

What Omicron could mean for the pandemic

What Omicron could mean for the pandemic

Miranda Hester
January 7th 2022
Podcast

Contemporary Pediatrics sat down with Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, to discuss what's known about the variant. She also discusses the latest on the vaccine for children aged younger than 5 years.

Study: Nearly 80% of infants born in 2023-24 RSV season received RSV protection | Image Credit: © Peter Hansen - © Peter Hansen - stock.adobe.com.

Study: Nearly 80% of infants born in 2023-24 RSV season received RSV protection

Joshua Fitch, Senior Editor
January 8th 2025
Article

The study within a single health care system revealed that most infants born prior to December received the nirsevimab monoclonal antibody.

COVID-19 Roundtable: Prophylaxis for the immunocompromised

COVID-19 Roundtable: Prophylaxis for the immunocompromised

Joshua Fitch, Senior Editor ;John Parkinson
December 24th 2024
Article

This week the panel weighs in on monoclonal antibodies in this patient population as well as important overall takeaways about COVID-19 therapies.

© 2025 MJH Life Sciences

All rights reserved.